China’s space program spent 2025 pushing its launch cadence to new heights, testing reusable rockets at scale and managing ...

Relays can be tiny elements, yet they play vital functions in electrical systems. They operate circuits, guard equipment, and ...

In an increasingly automated and energy-efficient world, single-phase solid-state relays (SSRs) stand out as essential components in modern heating and lighting systems. These extraordinary devices ...

Aside from offering to acquire all remaining shares of Neuphoria, existing investor Lynx1 Master Fund also announced its plan to nominate directors in the biotech’s upcoming board elections. Neuphoria ...

As Neuphoria Therapeutics considers its options in the wake of the failure of its phase 3 social anxiety program, an investor has swooped in with one potential escape route. Lynx1 Master Fund, a ...

AnaptysBio has abandoned plans to develop rosnilimab for ulcerative colitis (UC) after the PD-1 agonist flunked a phase 2 study. The San Diego-based biopharma assessed rosnilimab in the midstage study ...

Two Sarepta Therapeutics drugs for treating different genetic subsets of patients with Duchenne muscular dystrophy failed the confirmatory study required of their accelerated FDA approvals. Sarepta ...

Discover the hidden habits that help serial entrepreneurs succeed where most startups fail. Learn how storytelling, timing and pattern recognition give repeat founders a measurable edge. It’s easy to ...